Variable | Whole cohort (N = 1355) | Q1 sUA ≤ 288.1 (N = 339) | Q2 sUA 288.1–356 (N = 339) | Q3 sUA 356-437.5 (N = 340) | Q4 sUA > 437.5 (N = 337) | P value |
---|---|---|---|---|---|---|
Age (years) | 72.55 ± 8.02 | 72.60 ± 7.98 | 72.33 ± 7.73 | 72.69 ± 8.16 | 72.57 ± 8.22 | 0.946 |
Male (%) | 60.2 | 48.1 | 55.2 | 68.2ab | 69.4ab | < 0.001 |
Body mass index (kg/m2) | 24.79 ± 3.83 | 24.30 ± 3.90 | 25.05 ± 3.73a | 25.28 ± 3.76a | 24.53 ± 3.88c | 0.003 |
Systolic blood pressure (mmHg) | 135.19 ± 20.44 | 137.55 ± 21.45 | 137.13 ± 20.16 | 135.74 ± 18.83 | 130.32 ± 20.51abc | < 0.001 |
Diastolic blood pressure (mmHg) | 75.30 ± 12.32 | 75.74 ± 12.45 | 75.42 ± 12.33 | 75.54 ± 11.84 | 74.48 ± 12.68 | 0.560 |
Heart rate (bpm) | 77.44 ± 15.63 | 77.86 ± 15.98 | 77.01 ± 14.91 | 75.43 ± 15.38a | 79.47 ± 16.01bc | 0.008 |
Hypertension (%) | 74.6 | 72.0 | 74.9 | 73.8 | 77.7 | 0.374 |
Coronary artery disease (%) | 77.7 | 78.5 | 79.4 | 77.6 | 75.4 | 0.636 |
Diabetes mellitus (%) | 36.1 | 38.6 | 35.7 | 34.4 | 35.6 | 0.698 |
Atrial fibrillation (%) | 51.1 | 50.1 | 52.8 | 49.1 | 52.5 | 0.724 |
Chronic kidney disease (%) | 34.4 | 12.4 | 22.1a | 37.1ab | 66.2abc | < 0.001 |
D-dimer (ng/mL) | 0.995 ± 1.679 | 0.935 ± 1.679 | 0.758 ± 1.171 | 0.797 ± 0.944 | 1.493 ± 2.430abc | < 0.001 |
NT-proBNP (pg/mL) | 3199.13 ± 5299.74 | 2168.67 ± 3310.89 | 2189.35 ± 3007.43 | 2476.91 ± 4077.70 | 5980.14 ± 8117.76abc | < 0.001 |
Albumin (g/L) | 39.21 ± 4.14 | 38.77 ± 4.45 | 39.83 ± 3.84a | 39.63 ± 3.87a | 38.61 ± 4.24bc | < 0.001 |
Creatinine (mg/dL) | 97.22 ± 50.94 | 77.39 ± 38.28 | 86.44 ± 40.67a | 96.20 ± 32.96ab | 129.06 ± 68.48abc | < 0.001 |
Sodium (mmol/L) | 140.55 ± 3.92 | 140.57 ± 4.54 | 140.74 ± 3.72 | 140.92 ± 3.29 | 139.96 ± 3.98abc | 0.010 |
Cholesterol (mmol/L) | 3.88 ± 0.98 | 3.83 ± 1.00 | 4.00 ± 0.96a | 3.92 ± 0.98 | 3.79 ± 0.97b | 0.021 |
Haemoglobin (g/L) | 129.83 ± 19.81 | 127.59 ± 17.84 | 131.17 ± 17.73a | 132.32 ± 19.56a | 128.24 ± 23.31c | 0.004 |
LVEF (%) | 48.05 ± 11.68 | 50.09 ± 11.10 | 49.53 ± 11.13 | 48.14 ± 11.98a | 44.44 ± 11.70abc | < 0.001 |
Left atrial diameter (mm) | 41.67 ± 6.42 | 40.32 ± 6.46 | 41.29 ± 6.34a | 41.73 ± 6.03a | 43.35 ± 6.50abc | < 0.001 |
LVESD (mm) | 37.98 ± 9.47 | 35.73 ± 8.00 | 37.14 ± 8.85a | 38.24 ± 9.96a | 40.83 ± 10.21abc | < 0.001 |
LVEDD (mm) | 50.85 ± 8.82 | 48.73 ± 7.49 | 50.20 ± 8.17a | 51.26 ± 9.14a | 53.22 ± 9.73abc | < 0.001 |
ACEI or ARB (%) | 60.3 | 58.4 | 59.6 | 62.6 | 60.5 | 0.713 |
Calcium-channel blockers (%) | 44.5 | 44.5 | 45.1 | 44.1 | 44.2 | 0.993 |
Beta-blockers (%) | 74.0 | 70.8 | 76.7 | 71.5 | 77.2 | 0.113 |
Other diuretics (%) | 45.5 | 28.3 | 41.6a | 41.2a | 70.9abc | < 0.001 |
Digoxin (%) | 28.7 | 19.2 | 25.4 | 27.9a | 42.4abc | < 0.001 |
Nitrates (%) | 63.8 | 64.9 | 63.1 | 63.5 | 63.5 | 0.966 |
Aspirin/clopidogrel (%) | 77.3 | 76.7 | 79.4 | 82.1 | 70.9bc | 0.004 |
Warfarin (%) | 15.4 | 17.1 | 14.7 | 12.9 | 16.9 | 0.386 |
Statins (%) | 78.4 | 82.3 | 84.1 | 79.1 | 68.0abc | < 0.001 |
Spironolactone (%) | 45.9 | 31.9 | 41.3a | 46.5a | 64.1abc | < 0.001 |
Length of stay (days) | 11.33 ± 8.56 | 11.15 ± 8.64 | 10.74 ± 7.93 | 10.51 ± 7.24 | 12.92 ± 10.04abc | 0.001 |
NYHA class III/IV (%) | 36.3 | 26.9 | 26.5 | 35.0ab | 56.7abc | < 0.001 |